Recovery of Dysregulated Genes in Cancer-Related Lower Limb Lymphedema After Supermicrosurgical Lymphaticovenous Anastomosis – A Prospective Longitudinal Cohort Study

References

• Grada AA, Phillips TJ. Lymphedema: pathophysiology and clinical manifestations. J Am Acad Dermatol. 2017;77(6):1009–1020. doi:10.1016/j.jaad.2017.03.022
   PubMed Web of Science ®Google Scholar
• Dessources K, Aviki E, Leitao MM Jr. Lower extremity lymphedema in patients with gynecologic malignancies. Int J Gynecol Cancer. 2020;30(2):252–260. doi:10.1136/ijgc-2019-001032
   PubMed Web of Science ®Google Scholar
• Sung CJ, Wang SX, Hsu JF, Yu RP, Wong AK. Current understanding of pathological mechanisms of lymphedema. Adv Wound Care. 2021. doi:10.1089/wound.2021.0041
   Web of Science ®Google Scholar
• Beier A, Siems W, Brenke R, Grune T. [Increased formation of free radicals in chronic lymphedema]. Z Lymphol. 1994;18(1):8–11. German.
   PubMedGoogle Scholar
• Siems WG, Brenke R, Beier A, Grune T. Oxidative stress in chronic lymphoedema. QJM. 2002;95(12):803–809. doi:10.1093/qjmed/95.12.803
   PubMed Web of Science ®Google Scholar
• Foldi E, Sauerwald A, Hennig B. Effect of complex decongestive physiotherapy on gene expression for the inflammatory response in peripheral lymphedema. Lymphology. 2000;33(1):19–23.
   PubMed Web of Science ®Google Scholar
• Yang JC, Wu SC, Chiang MH, Lin WC, Chiang PL, Hsieh CH. Supermicrosurgical lymphaticovenous anastomosis as an alternative treatment option for moderate-to-severe lower limb lymphedema. J Am Coll Surg. 2020;230(2):216–227. doi:10.1016/j.jamcollsurg.2019.10.007
   PubMed Web of Science ®Google Scholar
• Yang JC, Yen YH, Wu SC, Lin WC, Chiang MH, Hsieh CH. Supermicrosurgical lymphaticovenous anastomosis as an alternative treatment option for patients with lymphorrhea. Plast Reconstr Surg. 2019;144(5):1214–1224. doi:10.1097/PRS.0000000000006169
   PubMed Web of Science ®Google Scholar
• Yang JC, Huang LH, Wu SC, et al. Lymphaticovenous anastomosis supermicrosurgery decreases oxidative stress and increases antioxidant capacity in the serum of lymphedema patients. J Clin Med. 2021;10(7):1540. doi:10.3390/jcm10071540
   PubMed Web of Science ®Google Scholar
• Levi B, Glotzbach JP, Sorkin M, et al. Molecular analysis and differentiation capacity of adipose-derived stem cells from lymphedema tissue. Plast Reconstr Surg. 2013;132(3):580–589. doi:10.1097/PRS.0b013e31829ace13
   PubMed Web of Science ®Google Scholar
• Xiang Q, Xu F, Li Y, et al. Transcriptome analysis and functional identification of adipose-derived mesenchymal stem cells in secondary lymphedema. Gland Surg. 2020;9(2):558–574. doi:10.21037/gs.2020.02.09
   PubMed Web of Science ®Google Scholar
• Koc M, Wald M, Varaliova Z, et al. Lymphedema alters lipolytic, lipogenic, immune and angiogenic properties of adipose tissue: a hypothesis-generating study in breast cancer survivors. Sci Rep. 2021;11(1):8171. doi:10.1038/s41598-021-87494-3
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Yamamoto N, Yoshimatsu H, Narushima M, Koshima I. Factors associated with lymphosclerosis: an analysis on 962 lymphatic vessels. Plast Reconstr Surg. 2017;140(4):734–741. doi:10.1097/PRS.0000000000003690
   PubMed Web of Science ®Google Scholar
• Zollbrecht C, Grassl M, Fenk S, et al. Expression pattern in human macrophages dependent on 9p21.3 coronary artery disease risk locus. Atherosclerosis. 2013;227(2):244–249. doi:10.1016/j.atherosclerosis.2012.12.030
   PubMed Web of Science ®Google Scholar
• Qian BZ, Li J, Zhang H, et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature. 2011;475(7355):222–225. doi:10.1038/nature10138
   PubMed Web of Science ®Google Scholar
• Li D, Ji H, Niu X, et al. Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer. Cancer Sci. 2020;111(1):47–58. doi:10.1111/cas.14230
   PubMed Web of Science ®Google Scholar
• Szekely B, Bossuyt V, Li X, et al. Immunological differences between primary and metastatic breast cancer. Ann Oncol. 2018;29(11):2232–2239. doi:10.1093/annonc/mdy399
   PubMed Web of Science ®Google Scholar
• De la Fuente Lopez M, Landskron G, Parada D, et al. The relationship between chemokines CCL2, CCL3, and CCL4 with the tumor microenvironment and tumor-associated macrophage markers in colorectal cancer. Tumour Biol. 2018;40(11):1010428318810059. doi:10.1177/1010428318810059
   Google Scholar
• Uchiyama T, Itaya-Hironaka A, Yamauchi A, et al. Intermittent hypoxia up-regulates CCL2, RETN, and TNFalpha mRNAs in adipocytes via down-regulation of miR-452. Int J Mol Sci. 2019;20(8):1960. doi:10.3390/ijms20081960
   PubMed Web of Science ®Google Scholar
• Kumar A, Shalmanova L, Hammad A, Christmas SE. Induction of IL-8(CXCL8) and MCP-1(CCL2) with oxidative stress and its inhibition with N-acetyl cysteine (NAC) in cell culture model using HK-2 cell. Transpl Immunol. 2016;35:40–46. doi:10.1016/j.trim.2016.02.003
   PubMed Web of Science ®Google Scholar
• Luciano-Mateo F, Cabre N, Fernandez-Arroyo S, et al. Chemokine (C-C motif) ligand 2 gene ablation protects low-density lipoprotein and paraoxonase-1 double deficient mice from liver injury, oxidative stress and inflammation. Biochim Biophys Acta Mol Basis Dis. 2019;1865(6):1555–1566. doi:10.1016/j.bbadis.2019.03.006
   PubMed Web of Science ®Google Scholar
• Seok SJ, Lee ES, Kim GT, et al. Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice. Nephrol Dial Transplant. 2013;28(7):1700–1710. doi:10.1093/ndt/gfs555
   PubMed Web of Science ®Google Scholar
• Brorson H, Svensson H. Complete reduction of lymphoedema of the arm by liposuction after breast cancer. Scand J Plast Reconstr Surg Hand Surg. 1997;31(2):137–143. doi:10.3109/02844319709085480
   PubMed Web of Science ®Google Scholar
• Mulumba M, Jossart C, Granata R, et al. GPR103b functions in the peripheral regulation of adipogenesis. Mol Endocrinol. 2010;24(8):1615–1625. doi:10.1210/me.2010-0010
   PubMedGoogle Scholar
• Bi Y, Yuan X, Chen Y, Chang G, Chen G. Expression analysis of genes related to lipid metabolism in peripheral blood lymphocytes of chickens challenged with reticuloendotheliosis virus. Poult Sci. 2021;100(5):101081. doi:10.1016/j.psj.2021.101081
   PubMed Web of Science ®Google Scholar
• Rogers C, Moukdar F, McGee MA, et al. EGF receptor (ERBB1) abundance in adipose tissue is reduced in insulin-resistant and type 2 diabetic women. J Clin Endocrinol Metab. 2012;97(3):E329–E340. doi:10.1210/jc.2011-1033
   PubMed Web of Science ®Google Scholar
• Renier G, Desfaits AC, Lambert A, Mikhail R. Role of oxidant injury on macrophage lipoprotein lipase (LPL) production and sensitivity to LPL. J Lipid Res. 1996;37(4):799–809. doi:10.1016/S0022-2275(20)37578-7
   PubMed Web of Science ®Google Scholar
• Maingrette F, Renier G. Leptin increases lipoprotein lipase secretion by macrophages: involvement of oxidative stress and protein kinase C. Diabetes. 2003;52(8):2121–2128. doi:10.2337/diabetes.52.8.2121
   PubMed Web of Science ®Google Scholar
• Peng J, Lv YC, He PP, et al. Betulinic acid downregulates expression of oxidative stress-induced lipoprotein lipase via the PKC/ERK/c-Fos pathway in RAW264.7 macrophages. Biochimie. 2015;119:192–203. doi:10.1016/j.biochi.2015.10.020
   PubMed Web of Science ®Google Scholar
• Oliveira JVB, Lima RPA, Pordeus Luna RC, et al. The direct correlation between oxidative stress and LDL-C levels in adults is maintained by the Friedewald and Martin equations, but the methylation levels in the MTHFR and ADRB3 genes differ. PLoS One. 2020;15(12):e0239989. doi:10.1371/journal.pone.0239989
   PubMed Web of Science ®Google Scholar
• Townsend LK, Weber AJ, Barbeau PA, Holloway GP, Wright DC. Reactive oxygen species-dependent regulation of pyruvate dehydrogenase kinase-4 in white adipose tissue. Am J Physiol Cell Physiol. 2020;318(1):C137–C149. doi:10.1152/ajpcell.00313.2019
   PubMed Web of Science ®Google Scholar
• Andersen E, Ingerslev LR, Fabre O, et al. Preadipocytes from obese humans with type 2 diabetes are epigenetically reprogrammed at genes controlling adipose tissue function. Int J Obes. 2019;43(2):306–318. doi:10.1038/s41366-018-0031-3
   Web of Science ®Google Scholar
• Li L, Kang H, Zhang Q, D’Agati VD, Al-Awqati Q, Lin F. FoxO3 activation in hypoxic tubules prevents chronic kidney disease. J Clin Invest. 2019;129(6):2374–2389. doi:10.1172/JCI122256
   PubMed Web of Science ®Google Scholar
• Deng A, Ma L, Zhou X, Wang X, Wang S, Chen X. FoxO3 transcription factor promotes autophagy after oxidative stress injury in HT22 cells. Can J Physiol Pharmacol. 2021;99(6):627–634. doi:10.1139/cjpp-2020-0448
   PubMed Web of Science ®Google Scholar
• Nlandu-Khodo S, Osaki Y, Scarfe L, et al. Tubular beta-catenin and FoxO3 interactions protect in chronic kidney disease. JCI Insight. 2020;5(10). doi:10.1172/jci.insight.135454
   PubMed Web of Science ®Google Scholar
• Wang LF, Huang CC, Xiao YF, et al. CD38 deficiency protects heart from high fat diet-induced oxidative stress via activating Sirt3/FOXO3 pathway. Cell Physiol Biochem. 2018;48(6):2350–2363. doi:10.1159/000492651
   PubMedGoogle Scholar
• Lv W, Jiang J, Li Y, Fu L, Meng F, Li J. MiR-302a-3p aggravates myocardial ischemia-reperfusion injury by suppressing mitophagy via targeting FOXO3. Exp Mol Pathol. 2020;117:104522. doi:10.1016/j.yexmp.2020.104522
   PubMed Web of Science ®Google Scholar
• Miyamoto N, Izumi H, Miyamoto R, et al. Nipradilol and timolol induce Foxo3a and peroxiredoxin 2 expression and protect trabecular meshwork cells from oxidative stress. Invest Ophthalmol Vis Sci. 2009;50(6):2777–2784. doi:10.1167/iovs.08-3061
   PubMed Web of Science ®Google Scholar
• Lee YJ. Knockout mouse models for peroxiredoxins. Antioxidants. 2020;9(2):182.
   Web of Science ®Google Scholar
• Banerji R, Saroj SD. Early growth response 1 (EGR1) activation in initial stages of host-pathogen interactions. Mol Biol Rep. 2021;48(3):2935–2943. doi:10.1007/s11033-021-06305-0
   PubMed Web of Science ®Google Scholar
• Wang B, Guo H, Yu H, Chen Y, Xu H, Zhao G. The role of the transcription factor EGR1 in cancer. Front Oncol. 2021;11:642547. doi:10.3389/fonc.2021.642547
   PubMed Web of Science ®Google Scholar
• Li TT, Liu MR, Pei DS. Friend or foe, the role of EGR-1 in cancer. Med Oncol. 2019;37(1):7. doi:10.1007/s12032-019-1333-6
   PubMed Web of Science ®Google Scholar
• Li J, Gong L, Zhang R, et al. Fibroblast growth factor 21 inhibited inflammation and fibrosis after myocardial infarction via EGR1. Eur J Pharmacol. 2021;910:174470. doi:10.1016/j.ejphar.2021.174470
   PubMedGoogle Scholar
• Gruosso T, Garnier C, Abelanet S, et al. MAP3K8/TPL-2/COT is a potential predictive marker for MEK inhibitor treatment in high-grade serous ovarian carcinomas. Nat Commun. 2015;6:8583. doi:10.1038/ncomms9583
   PubMed Web of Science ®Google Scholar
• Xu Z, Tong Q, Zhang Z, et al. Inhibition of HDAC3 prevents diabetic cardiomyopathy in OVE26 mice via epigenetic regulation of DUSP5-ERK1/2 pathway. Clin Sci. 2017;131(15):1841–1857. doi:10.1042/CS20170064
   Web of Science ®Google Scholar
• Ng KY, Chan LH, Chai S, et al. TP53INP1 downregulation activates a p73-dependent dusp10/erk signaling pathway to promote metastasis of hepatocellular carcinoma. Cancer Res. 2017;77(17):4602–4612. doi:10.1158/0008-5472.CAN-16-3456
   PubMed Web of Science ®Google Scholar
• Chuang HC, Tan TH. MAP4K family kinases and DUSP family phosphatases in T-cell signaling and systemic lupus erythematosus. Cells. 2019;8(11):1433. doi:10.3390/cells8111433
   PubMed Web of Science ®Google Scholar
• Seo H, Cho YC, Ju A, et al. Dual-specificity phosphatase 5 acts as an anti-inflammatory regulator by inhibiting the ERK and NF-kappaB signaling pathways. Sci Rep. 2017;7(1):17348. doi:10.1038/s41598-017-17591-9
   PubMed Web of Science ®Google Scholar
• Liu T, Sun H, Liu S, et al. The suppression of DUSP5 expression correlates with paclitaxel resistance and poor prognosis in basal-like breast cancer. Int J Med Sci. 2018;15(7):738–747. doi:10.7150/ijms.24981
   PubMed Web of Science ®Google Scholar
• Chen HF, Chuang HC, Tan TH. Regulation of dual-specificity phosphatase (DUSP) ubiquitination and protein stability. Int J Mol Sci. 2019;20(11):2668.
   PubMed Web of Science ®Google Scholar
• Png CW, Weerasooriya M, Guo J, et al. DUSP10 regulates intestinal epithelial cell growth and colorectal tumorigenesis. Oncogene. 2016;35(2):206–217. doi:10.1038/onc.2015.74
   PubMed Web of Science ®Google Scholar
• Ding J, Li J, Wang H, et al. Long noncoding RNA CRNDE promotes colorectal cancer cell proliferation via epigenetically silencing DUSP5/CDKN1A expression. Cell Death Dis. 2017;8(8):e2997. doi:10.1038/cddis.2017.328
   PubMed Web of Science ®Google Scholar
• Kidger AM, Rushworth LK, Stellzig J, et al. Dual-specificity phosphatase 5 controls the localized inhibition, propagation, and transforming potential of ERK signaling. Proc Natl Acad Sci U S A. 2017;114(3):E317–E326. doi:10.1073/pnas.1614684114
   PubMed Web of Science ®Google Scholar
• Min H, He W. Long non-coding RNA ARAP1-AS1 promotes the proliferation and migration in cervical cancer through epigenetic regulation of DUSP5. Cancer Biol Ther. 2020;21(10):907–914. doi:10.1080/15384047.2020.1806641
   PubMed Web of Science ®Google Scholar
• Wang L, Hu J, Qiu D, et al. Dual-specificity phosphatase 5 suppresses ovarian cancer progression by inhibiting IL-33 signaling. Am J Transl Res. 2019;11(2):844–854.
   PubMed Web of Science ®Google Scholar
• Donlon TA, Morris BJ, Chen R, et al. FOXO3 longevity interactome on chromosome 6. Aging Cell. 2017;16(5):1016–1025. doi:10.1111/acel.12625
   PubMed Web of Science ®Google Scholar
• Canzoneri R, Naipauer J, Stedile M, et al. Identification of an AP1-ZFP36 regulatory network associated with breast cancer prognosis. J Mammary Gland Biol Neoplasia. 2020;25(2):163–172. doi:10.1007/s10911-020-09448-1
   PubMed Web of Science ®Google Scholar